BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

Novel microtubule-targeting agent largely avoids neuropathy

Nov. 18, 2016
By Anette Breindl

In cancer therapy, chemotherapy is the workhorse to immuno-oncology's and targeted therapy's show horses.


Read More

Lyndra's long-acting oral drug delivery capsule a hoped for star on the horizon

Nov. 17, 2016
By Anette Breindl

Long-acting oral drug delivery star on horizon

Nov. 17, 2016
By Anette Breindl
A new drug delivery device that stays in the stomach and slowly releases its contents could replace daily pills with weekly or even monthly ones.
Read More

Bench Press: BioWorld looks at translational medicine

Nov. 14, 2016
By Anette Breindl
Autoimmune antibodies can ravage the body – or not: Many individuals have measurable autoantibodies for years before the onset of clinical symptoms, and even once clinical disease is present, antibody titers do not correlate with disease severity.
Read More

Cachexia is linked to immunotherapy failure

Nov. 14, 2016
By Anette Breindl
Researchers have linked metabolic changes in the wasting syndrome cachexia to the inability to mount an antitumor immune response.
Read More

Neurotransmitter GABA could be target for antidepressants

Nov. 11, 2016
By Anette Breindl
Currently, standard antidepressants – the selective serotonin reuptake inhibitors (SSRIs) – target serotonin. But serotonin is far from the only transmitter that is out of balance in depression.
Read More

Circuit-specific receptor targeting fights epilepsy

Nov. 10, 2016
By Anette Breindl
By targeting a so-called auxiliary protein, researchers have selectively inhibited specific neural circuits whose malfunction underlies one form of epilepsy.
Read More

'Strips' of heart tissue improve cardiac functio

Nov. 8, 2016
By Anette Breindl

Stimulating, blocking rapid-acting estrogen receptor both beneficial

Nov. 7, 2016
By Anette Breindl
"The average scientist thinks of estrogen as largely mediating gene expression," Eric Prossnitz told BioWorld Today. Estrogen is a steroid hormone, and its classical receptor is a nuclear hormone receptor that acts as a transcription factor once it is activated by estrogen binding.
Read More

Bench Press: BioWorld looks at translational medicine

Nov. 7, 2016
By Anette Breindl
After injury, zebrafish can send axons across severed spinal cords and regenerate neural connections. Now, researchers from Duke University have identified a molecule that is important for enabling them to do so.
Read More
View All Articles by Anette Breindl

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing